Clinical outcomes for low-income patients with early-onset breast cancer: An analysis of the National Inpatient Sample.

B Ben Brik (1Jefferson Health - New Jersey, Stratford, United States) T Tony Elias (2Temple University, Philadelphia, United States) V Vineet Polineni (1Jefferson Health - New Jersey, Stratford, United States) D Danielle Claire Thor (Jefferson Health New Jersey, Stratford, NJ) M Mahija Cheekati (3Ochsner Clinic Foundation, New Orleans, United States)

Abstract

11183 Background: Despite recent global decreases in overall cancer incidence, the incidence of early-onset breast cancer (EOBC) is steadily increasing globally. Limited data is available on the comorbid correlations for this unfortunately expanding population. We sought to examine the national inpatient sample database to describe in-hospital outcomes among low-income patients with EOBC. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for 2019 and 2020. The NIS was searched for hospitalizations of adult patients with EOBC, defined as all-cause breast cancer in patients 50 years old or younger. We then examined the outcomes of patients who self-reported an income less than $50,000. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality and secondary outcomes were annotated accordingly. SPSS software was used for statistical analysis, and all results were powered to p<0.001. Results: This study included 10,764 patients with EOBC, of which 2743 (25.5%) were low-income. Multivariate regression showed that low-income patients with EOBC had higher inpatient mortality (OR 1.438, CI 1.348-1.534, p<0.001). On secondary analysis, low-income patients with EOBC were more likely to have systemic lupus erythematosus (OR 1.298, CI 1.146-1.470), anemia (OR 1.374, CI 1.347-1.402), thrombocytopenia (OR 1.356, CI 1.302-1.412), hypertension (OR 1.545, CI 1.434-1.666), chronic kidney disease (OR 1.531, CI 1.404-1.669), acute renal failure (OR 1.462, CI 1.393-1.535), pancreatitis (OR 1.479, CI 1.259-1.738), mitral regurgitation (OR 1.300, CI 1.151-1.468), pericarditis (OR 1.358, CI 1.254-1.471), intracranial hemorrhage (OR 1.373, CI 1.190-1.584), pulmonary hypertension (OR 1.542, CI 1.326-1.794), severe liver disease (OR 1.382, CI 1.346-1.419), leukemia (OR 1.407, CI 1.149-1.724), lymphoma (OR 1.320, CI 1.088-1.601), all-cause arrhythmias (OR 1.324, CI 1.241-1.413), all-cause shock (OR 1.414, CI 1.264-1.605), all-cause heart block (OR 1.479, CI 1.172-1.719), all-cause sepsis (OR 1.409, CI 1.368-1.451), all-cause coagulopathy (OR 1.415, CI 1.327-1.508), all-cause heart failure (OR 1.508, CI 1.402-1.623), all-cause stroke (OR 1.463, CI 1.331-1.549), and all-cause myocardial infarction (OR 1.527, CI 1.336-1.746). Conclusions: In this nationally representative, population‐based retrospective cohort study, low-income patients with EOBC were associated with higher mortality and worse outcomes.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 11183-11183
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (5)

B

Ben Brik

1Jefferson Health - New Jersey, Stratford, United States

T

Tony Elias

2Temple University, Philadelphia, United States

V

Vineet Polineni

1Jefferson Health - New Jersey, Stratford, United States

D

Danielle Claire Thor

Jefferson Health New Jersey, Stratford, NJ

M

Mahija Cheekati

3Ochsner Clinic Foundation, New Orleans, United States